Headquarters
United States
team size
5 - 9
founded
2010
website
http://arraybridge.com
funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
Offices
United States
HQ address
4320 Forest Park Ave., St Louis, 63108, USA
Email
xing.wang@arraybridge.com
description
Protein conformation is important to its function, for therapeutic proteins the three-dimensional (3-D) structure is closely related to their safety and efficacy. Considerable resources are invested in the evaluation of therapeutic protein immunogenicity, a major concern in biologics development. Many technologies have been used to characterize therapeutic protein 3-D structure, the most commonly used technologies include Near UV CD, Analytical Ultracentrifugation, Gel Filtration (Size Exclusion), NMR and Hydrogen/deuterium Exchange (HDX). However a more sensitive, systematic and high throughput method will be beneficial to the development of large number of biologics molecules or to characterize each biologics in much detail. Antibody Conformational Arrays were developed in an easy-to-use ELISA format, providing sensitivities at molecular level and has the capability to measure a large number of samples simultaneously (www.arraybridge.com).

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats